CTOs on the Move

Preventure

www.preventure.com

 
Rooted in Relationships, Backed by Results. Our Mission is to revolutionize the perception and impact of employee well-being by creating and proving the correlation of employee well-being with bottom line revenue. To help medium and large-sized organizations by deploying and managing tailored programs that are customized for every client and personalized for each participant. To deliver total Return on Well-being for every client, including individual health improvement, heightened employee engagement, increased productivity, cultural improvement, lower healthcare costs, and higher profitability. Our Vision is to revolutionize the way corporate America values employee well-being by correlating improved employee health and employee engagement with decreased ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details
Barry Silver
Vice President of Technology Operations Profile

Similar Companies

GuideWell

GuideWell Source is a leading administrative services company providing full-service, end-to-end business services for health plans and government sponsored health care programs.

Quality Health

Quality Health is a Jersey City, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Tru-Tain Inc

Tru-Tain Inc is a Rochester, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Central Connecticut Coast YMCA

Since 1859 the Central Connecticut Coast Y branches have served as community centers in the heart of the twenty-five towns we serve. Much of the Central Connecticut Coast Y’s work is supported by membership dues, program fees and grants, but central to...

Sarepta

Sarepta Therapeutics, headquartered in Cambridge, Massachusetts, is a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicine to treat rare diseases. Sarepta is at the forefront of precision genetic medicine, having built an impressive and competitive position in Duchenne muscular dystrophy (DMD) and more recently in Limb-girdle muscular dystrophy (LGMD), Charcot-Marie-Tooth (CMT) and CNS-related disorders, reaching a total of over 20 therapies in various stages of development. The Company`s programs span across several therapeutic modalities, including RNA, gene therapy and gene editing. Sarepta is poised to be the most meaningful precision genetic medicine company in the world and make a profound difference in the lives of patients suffering from rare neuromuscular diseases and other rare diseases.